Nederlands
English
About VIB
Currently selected
Science communication
Home
>
About VIB
>
Press
Refine
Theme
About VIB (92)
Arabidopsis (3)
Bioinformatics (11)
Biotech basics (1)
Cancer (69)
Cardiovascular medicine (11)
Cell biology (9)
Grand Challenges (4)
Immunology (32)
Inflammation and immunity (55)
Microbiology (23)
Model Organisms (4)
Mouse (2)
Neuroscience (59)
Plant biology (41)
Proteomics (5)
Research Areas (3)
Science ethics (2)
Structural biology (17)
Systems biology (2)
Yeast (1)
Category
BioInformatics Training and Service facility (1)
Business opportunities (8)
Developmental biology (1)
Event (8)
News (34)
Research services (5)
Page Content Zone 1
Press
Receive VIB press releases
Email updates
Follow us on Twitter
Like us on Facebook
RSS
Contact
For all press inquiries, contact
Katrina Wright
Tel.: +32 9 244 66 11
Recent press releases
First Closing of V-Bio Ventures
2 January 2016
V-Bio Ventures announced a first closing with capital commitments of € 63 million. We asked Christina Takke and Willem Broekaert, both Managing Partners and founders of V-Bio Ventures, to comment on what the next steps are.
Start me up! A closer look at new ventures based on breakthrough science
28 December 2015
VIB’s tech transfer system is a striking illustration of how ground-breaking science and impact on society go hand in hand. Our patents can lead to license agreements with existing companies, but also to brand-new ventures.
A novel mechanism that helps activated dendritic cells to initiate effective immunity
18 December 2015
Phagocytosis represents a critical innate barrier against infection and serves the clearance of extracellular microbes, infected and dying cells. The results are published in the December issue of the prestigious journal Immunity.
VIB Core Facilities: technology suites for better science
18 December 2015
In terms of new technologies VIB is experiencing more exciting times than ever. The same applies to VIB’s Core Facilities. As specialized units, they provide state-of-the-art equipment, expertise and experience.
Research reveals promising novel strategy to target cancer-causing protein
15 December 2015
A team of scientists, comprising researchers from IMCB, A*STAR, VIB/KU Leuven has revealed the mechanism by which tumor cells elevate levels of MDM4, a protein that is highly expressed in cancer cells but not in normal adult tissues.
One step closer towards to unravelling the origins of Alzheimer’s disease
15 December 2015
Which risk genes deserve a closer look in medical research on the origins of Alzheimer’s disease? In 2011, a genome-wide association study (GWAS) formulated an answer to this question.
A wake-up call for biomedical research on mouse models
15 December 2015
Tom Vanden Berghe and colleagues from the Peter Vandenabeele Lab (VIB/UGent) have demonstrated how the side effects of genetic modification of mice can complicate the interpretation of biomedical research.
Quickscan
15 December 2015
Several publications from VIB researchers
Tech Watch for adoption and development of novel technologies at VIB
15 December 2015
VIB’s Tech Watch program has helped establish many VIB projects with emerging companies in fields such as Microscopy, Genome Engineering, DNA synthesis, Sequencing, Protein Affinity Reagents, Protein Analysis and many more.
Vaccine candidate for RSV well tolerated in patients in first part of Phase 1 clinical trial
15 December 2015
Immunovaccine Inc., a clinical stage vaccine and immunotherapy company, announced its Respiratory Syncytial Virus vaccine candidate was well tolerated in the Phase 1 study’s first 20 participants, of which 8 subjects received the DPX-RSV vaccine.
Francqui Chair for Adrian Liston
15 December 2015
Adrian Liston (VIB/KU Leuven) has been awarded the prestigious Belgian FrancquiChair 2015 - 2016 by the Free University of Brussels.
Women in Science Fellowship for Xenia Geeraerts (VIB/VUB)
15 December 2015
Xenia Geeraerts (PhD student at the VIB/VUB) was granted the L'Oréal-UNESCO for Women in Science Fellowship. Her research focuses on the regulation of the macrophage metabolism and phenotype by acidosis in the tumor micro-environment.
ERC Consolidator Grants for four VIB scientists: boost for innovative research
15 December 2015
The European Research Council (ERC) has awarded 4 VIB scientists a consolidator grant: Kevin Verstrepen (VIB/KU Leuven), Adrian Liston (VIB/KU Leuven), Mohamed Lamkanfi (VIB/UGent) and Daniël Van Damme (VIB/UGent).
Intellectual Property Rights as vital premise for VIB
14 December 2015
Intellectual Property (IP) Rights constitute a meaningful share of today’s academic environment. Referring to unique and value-adding creations of the human mind, this right serves as the foundation of collaboration between VIB and industrial partners.
Bringing industry and academia together
14 December 2015
By engaging with companies, we aim to translate basic research into products for patients and consumers, to create jobs and to raise money for top-level scientific research.
«Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
Next»
Page Content Zone 2
Page Content Zone 3